首页 > 最新文献

Revista espanola de medicina nuclear e imagen molecular最新文献

英文 中文
Pulmonary radioguided occult lesion localization (ROLL): Retrograde migration of 99mTc MAA to the upper airways and stomach. 肺放射引导隐匿病灶定位(ROLL): 99mTc MAA逆行迁移到上气道和胃。
Pub Date : 2025-11-18 DOI: 10.1016/j.remnie.2025.500253
L N Lemos, M De Bonilla Candau, A Palomar-Muñoz, A García, L S de Marconi, L R Álvarez
{"title":"Pulmonary radioguided occult lesion localization (ROLL): Retrograde migration of 99mTc MAA to the upper airways and stomach.","authors":"L N Lemos, M De Bonilla Candau, A Palomar-Muñoz, A García, L S de Marconi, L R Álvarez","doi":"10.1016/j.remnie.2025.500253","DOIUrl":"10.1016/j.remnie.2025.500253","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500253"},"PeriodicalIF":0.0,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integration of the nursing care assistant profile in I-125 seed procedures for breast cancer: Clinical and professional impact. I-125乳腺癌种子程序中护理助理档案的整合:临床和专业影响。
Pub Date : 2025-11-17 DOI: 10.1016/j.remnie.2025.500251
J Ribera-Perianes, P Moller Trigo, M A Blanco Recuero, X Cases Moreno, J Cortés Gracia, R Crespo Calvo, S Vidal-Sicart

Introduction: In response to the increasing demand for radioguided procedures, the integration of the Nursing Care Assistants (NCA) profile was proposed as support professionals in the preoperative marking of breast cancer (BC) patients using I-125 seeds.

Objectives: To analyze the clinical impact and professional development resulting from the integration of NCA into these procedures, assessing the operational efficiency of the Radioguided Surgery Team (RGST) and the training process that enabled them to assume new competencies.

Materials and methods: A four-phase theoretical-practical training program was implemented (theoretical instruction, practical mentoring, clinical simulation, and supervised autonomous practice), aimed at training NCA to assist in the localization and marking of non-palpable lesions and metastatic axillary lymph nodes using I-125 seeds. After completing the training, their impact was evaluated through a comparative analysis of RGST activity in 2023 and 2024.

Results: During the study period, NCA autonomously performed 116 marking procedures with I-125 seeds without incidents, accounting for 11.8% of total procedures in 2023 (32/270) and 23% in 2024 (84/366). Operational support was required on 21 working days in 2023 (8.5%) and 49 days in 2024 (19.6%), indicating a significant increase in their involvement.

Conclusions: The incorporation of the NCA profile into radioguided marking procedures has proven to be an effective strategy for optimizing healthcare resources, enhancing the operational efficiency of the RGST, and promoting the professional development of this role within highly specialized clinical settings.

导语:为了应对对放射引导手术日益增长的需求,建议将护理助理(TCAE)档案整合为使用I-125种子对乳腺癌(BC)患者进行术前标记的支持专业人员。目的:分析将TCAE整合到这些程序中所产生的临床影响和专业发展,评估放射引导外科团队(EQCRG)的操作效率和使他们能够承担新能力的培训过程。材料和方法:实施理论-实践四阶段培训计划(理论指导、实践指导、临床模拟和监督自主实践),旨在培训TCAE协助使用I-125种子定位和标记非可触及病变和转移性腋窝淋巴结。培训完成后,通过对2023年和2024年EQCRG活动的对比分析,对其影响进行了评估。结果:研究期间,TCAE对I-125种子进行了116次无事故自主标记,占2023年总数的11.8%(32/270),占2024年总数的23%(84/366)。2023年需要21个工作日(8.5%),2024年需要49个工作日(19.6%),这表明他们的参与显著增加。结论:将TCAE概况纳入放射性引导标记程序已被证明是优化医疗资源、提高EQCRG的操作效率以及在高度专业化的临床环境中促进这一角色的专业发展的有效策略。
{"title":"Integration of the nursing care assistant profile in I-125 seed procedures for breast cancer: Clinical and professional impact.","authors":"J Ribera-Perianes, P Moller Trigo, M A Blanco Recuero, X Cases Moreno, J Cortés Gracia, R Crespo Calvo, S Vidal-Sicart","doi":"10.1016/j.remnie.2025.500251","DOIUrl":"10.1016/j.remnie.2025.500251","url":null,"abstract":"<p><strong>Introduction: </strong>In response to the increasing demand for radioguided procedures, the integration of the Nursing Care Assistants (NCA) profile was proposed as support professionals in the preoperative marking of breast cancer (BC) patients using I-125 seeds.</p><p><strong>Objectives: </strong>To analyze the clinical impact and professional development resulting from the integration of NCA into these procedures, assessing the operational efficiency of the Radioguided Surgery Team (RGST) and the training process that enabled them to assume new competencies.</p><p><strong>Materials and methods: </strong>A four-phase theoretical-practical training program was implemented (theoretical instruction, practical mentoring, clinical simulation, and supervised autonomous practice), aimed at training NCA to assist in the localization and marking of non-palpable lesions and metastatic axillary lymph nodes using I-125 seeds. After completing the training, their impact was evaluated through a comparative analysis of RGST activity in 2023 and 2024.</p><p><strong>Results: </strong>During the study period, NCA autonomously performed 116 marking procedures with I-125 seeds without incidents, accounting for 11.8% of total procedures in 2023 (32/270) and 23% in 2024 (84/366). Operational support was required on 21 working days in 2023 (8.5%) and 49 days in 2024 (19.6%), indicating a significant increase in their involvement.</p><p><strong>Conclusions: </strong>The incorporation of the NCA profile into radioguided marking procedures has proven to be an effective strategy for optimizing healthcare resources, enhancing the operational efficiency of the RGST, and promoting the professional development of this role within highly specialized clinical settings.</p>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500251"},"PeriodicalIF":0.0,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145558557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the diagnostic efficacy of [18F]FDG PET radiomic analysis for tumor differentiation in patients with non-small cell lung cancer. [18F]FDG - PET放射组学分析对非小细胞肺癌患者肿瘤分化的诊断效果评价。
Pub Date : 2025-11-17 DOI: 10.1016/j.remnie.2025.500250
Xavier Boulvard Chollet, María P Garrastachu Zumarán, Leonardo G Romero Robles, Albert Santapau Traveria, M Clara Albornoz Almada, Rafael Ramírez Lasanta, José G Pichel, Roberto C Delgado Bolton

Purpose: The aim of this study was to evaluate the utility of radiomics based on [18F]FDG PET/CT imaging for the prediction of histological differentiation grade in patients with non-small cell lung cancer (NSCLC) of either adenocarcinoma or squamous cell carcinoma subtype.

Materials and methods: A single-center retrospective observational study was conducted, including 150 patients with histologically confirmed NSCLC who underwent [18F]FDG PET/CT imaging prior to complete surgical resection of the tumor. Patients were excluded if they showed no significant FDG uptake, lacked differentiation data, or had insufficient tumor volume. Image segmentation and feature extraction were performed using LIFEx software, obtaining both textural and morphological features. Predictive variables were selected using classical statistical techniques and LASSO regression, and model performance was evaluated using ROC curve analysis.

Results: Among the 150 patients included, 25 had well-differentiated tumors, 88 moderately differentiated, and 37 had poorly differentiated. Comparison between well-differentiated tumors and those with moderate or poor differentiation revealed statistically significant differences in several radiomic features. The LASSO model identified seven variables with high discriminative power. The model achieved a sensitivity of 76%, specificity of 99.2%, positive predictive value of 95%, negative predictive value of 95.4%, and an overall accuracy of 95.3%.

Conclusions: Radiomic features extracted from [18F]FDG PET/CT images can predict tumor differentiation grade in NSCLC with high specificity. This non-invasive approach may serve as a valuable adjunct to histopathological evaluation, potentially aiding clinical decision-making.

目的:本研究的目的是评估基于[18F]FDG PET/CT成像的放射组学在预测腺癌或鳞状细胞癌亚型非小细胞肺癌(NSCLC)患者组织学分化等级中的应用价值。材料与方法:本研究采用单中心回顾性观察性研究,纳入150例经组织学证实的非小细胞肺癌患者,在完全手术切除肿瘤前行FDG PET/CT成像[18F]。如果患者没有明显的FDG摄取、缺乏分化数据或肿瘤体积不足,则排除。使用LIFEx软件对图像进行分割和特征提取,获得纹理和形态特征。采用经典统计技术和LASSO回归选择预测变量,采用ROC曲线分析评价模型性能。结果:纳入的150例患者中,高分化25例,中分化88例,低分化37例。分化良好的肿瘤与中度或低分化的肿瘤的比较显示了几种放射学特征的统计学差异。LASSO模型识别出7个具有高判别能力的变量。该模型的敏感性为76%,特异性为99.2%,阳性预测值为95%,阴性预测值为95.4%,总体准确率为95.3%。结论:从[18F]FDG PET/CT图像中提取的放射学特征可以高特异性地预测非小细胞肺癌的肿瘤分化等级。这种非侵入性方法可以作为组织病理学评估的有价值的辅助手段,潜在地帮助临床决策。
{"title":"Evaluation of the diagnostic efficacy of [18F]FDG PET radiomic analysis for tumor differentiation in patients with non-small cell lung cancer.","authors":"Xavier Boulvard Chollet, María P Garrastachu Zumarán, Leonardo G Romero Robles, Albert Santapau Traveria, M Clara Albornoz Almada, Rafael Ramírez Lasanta, José G Pichel, Roberto C Delgado Bolton","doi":"10.1016/j.remnie.2025.500250","DOIUrl":"10.1016/j.remnie.2025.500250","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to evaluate the utility of radiomics based on [<sup>18</sup>F]FDG PET/CT imaging for the prediction of histological differentiation grade in patients with non-small cell lung cancer (NSCLC) of either adenocarcinoma or squamous cell carcinoma subtype.</p><p><strong>Materials and methods: </strong>A single-center retrospective observational study was conducted, including 150 patients with histologically confirmed NSCLC who underwent [<sup>18</sup>F]FDG PET/CT imaging prior to complete surgical resection of the tumor. Patients were excluded if they showed no significant FDG uptake, lacked differentiation data, or had insufficient tumor volume. Image segmentation and feature extraction were performed using LIFEx software, obtaining both textural and morphological features. Predictive variables were selected using classical statistical techniques and LASSO regression, and model performance was evaluated using ROC curve analysis.</p><p><strong>Results: </strong>Among the 150 patients included, 25 had well-differentiated tumors, 88 moderately differentiated, and 37 had poorly differentiated. Comparison between well-differentiated tumors and those with moderate or poor differentiation revealed statistically significant differences in several radiomic features. The LASSO model identified seven variables with high discriminative power. The model achieved a sensitivity of 76%, specificity of 99.2%, positive predictive value of 95%, negative predictive value of 95.4%, and an overall accuracy of 95.3%.</p><p><strong>Conclusions: </strong>Radiomic features extracted from [<sup>18</sup>F]FDG PET/CT images can predict tumor differentiation grade in NSCLC with high specificity. This non-invasive approach may serve as a valuable adjunct to histopathological evaluation, potentially aiding clinical decision-making.</p>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500250"},"PeriodicalIF":0.0,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145558801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Granulocyte-colony stimulating factor-associated aortitis on 18F-FDG PET/CT. 18F-FDG PET/CT显示粒细胞集落刺激因子相关性主动脉炎。
Pub Date : 2025-11-17 DOI: 10.1016/j.remnie.2025.500256
R Jordà-Sánchez, M Ortiz-Fernández, I A Hernández, Á Muxi, S Prieto-González
{"title":"Granulocyte-colony stimulating factor-associated aortitis on <sup>18</sup>F-FDG PET/CT.","authors":"R Jordà-Sánchez, M Ortiz-Fernández, I A Hernández, Á Muxi, S Prieto-González","doi":"10.1016/j.remnie.2025.500256","DOIUrl":"10.1016/j.remnie.2025.500256","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500256"},"PeriodicalIF":0.0,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145558493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diffuse large B-cell lymphoma mimicking as Erdheim–Chester disease on 18F-FDG PET/CT 弥漫性大b细胞淋巴瘤在18F-FDG PET/CT上与厄德海姆-切斯特病相似。
Pub Date : 2025-11-01 DOI: 10.1016/j.remnie.2025.500156
L. Yang , P. Dong , L. Li, M. Su
{"title":"Diffuse large B-cell lymphoma mimicking as Erdheim–Chester disease on 18F-FDG PET/CT","authors":"L. Yang ,&nbsp;P. Dong ,&nbsp;L. Li,&nbsp;M. Su","doi":"10.1016/j.remnie.2025.500156","DOIUrl":"10.1016/j.remnie.2025.500156","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"44 6","pages":"Article 500156"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144295558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifocal bone tuberculosis with adrenal involvement mimicking malignant tumors with multiple metastases on PET/CT 累及肾上腺的多灶性骨结核在PET/CT上表现为恶性肿瘤伴多发转移。
Pub Date : 2025-11-01 DOI: 10.1016/j.remnie.2025.500141
W. Zhang, Y. Xing, A. Kuang, Y. Li
{"title":"Multifocal bone tuberculosis with adrenal involvement mimicking malignant tumors with multiple metastases on PET/CT","authors":"W. Zhang,&nbsp;Y. Xing,&nbsp;A. Kuang,&nbsp;Y. Li","doi":"10.1016/j.remnie.2025.500141","DOIUrl":"10.1016/j.remnie.2025.500141","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"44 6","pages":"Article 500141"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse reactions mediated by 99mTc-tetrofosmin: Literature review and analysis of post-marketing reports 99mTc-tetrofosmin介导的不良反应:文献综述及上市后报告分析。
Pub Date : 2025-11-01 DOI: 10.1016/j.remnie.2025.500166
S. Martins , S. Costa , M. Sousa , F. Moreira , A. Martín-Suaréz , Â. Jesus

Introduction

99mTc-tetrofosmin is a diagnostic radiopharmaceutical used to evaluate cardiac pathologies. Despite the lower incidence of reactions compared to other drugs, radiopharmaceuticals can still cause adverse reactions. For this reason, pharmacovigilance plays a crucial role in detecting, understanding, evaluating and preventing them.

Objective

This study aims to review the available literature,on the safety of 99mTc-tetrofosmin, and to analyze spontaneous adverse drug reaction reports from the European EudraVigilance database.

Methods

A literature review was conducted according to PRISMA methodology. An analysis of spontaneous notifications was carried out in EudraVigilance, until 2022.

Results

The review identified a selection of 7 articles. The most reported adverse reactions were skin irritation, strange taste in the mouth and nausea. Regarding the EudraVigilance analysis, 220 notifications were identified, accounting for 477 adverse reactions. The majority belong to males (51%), between 18-64 years (45%). Health professionals were the main reporters (84%). The most prevalent System Organ Class was “general disorders and administration site conditions” (21%) and the most reported adverse reaction was pruritus (10%). Approximately 67% of reactions were considered serious, with 6 fatal cases recorded.

Conclusion

The results demonstrated that adverse reactions associated with 99mTc-tetrofosmin do occur and should not be minimized. Over a period of 17 years, only 220 notifications were recorded, which may highlight potential challenges in pharmacovigilance for radiopharmaceuticals. Therefore, raising awareness about the importance of reporting adverse reactions is crucial.
简介:99mTc-tetrofosmin是一种用于评估心脏病理的诊断性放射性药物。尽管与其他药物相比,放射性药物的反应发生率较低,但仍可能引起不良反应。因此,药物警戒在发现、认识、评价和预防这些疾病方面起着至关重要的作用。目的:本研究旨在分析99mTc-tetrofosmin的不良反应概况。方法:采用PRISMA方法进行文献复习。在欧洲警戒区对自发通报进行了分析,直到2022年。结果:本综述筛选出7篇文章。报告最多的不良反应是皮肤刺激、口腔异味和恶心。关于EudraVigilance分析,确定了220份通报,占477个不良反应。大多数是男性(51%),年龄在18-64岁之间(45%)。卫生专业人员是主要的报告者(84%)。最常见的系统器官分类是“一般疾病和给药部位状况”(21%),报告最多的不良反应是瘙痒(10%)。大约67%的反应被认为是严重的,有6例死亡记录。结论:99mTc-tetrofosmin相关不良反应确实存在,不应尽量减少。在17年期间,仅报告了220份通报,突出了少报的问题。因此,提高对报告不良反应重要性的认识至关重要。
{"title":"Adverse reactions mediated by 99mTc-tetrofosmin: Literature review and analysis of post-marketing reports","authors":"S. Martins ,&nbsp;S. Costa ,&nbsp;M. Sousa ,&nbsp;F. Moreira ,&nbsp;A. Martín-Suaréz ,&nbsp;Â. Jesus","doi":"10.1016/j.remnie.2025.500166","DOIUrl":"10.1016/j.remnie.2025.500166","url":null,"abstract":"<div><h3>Introduction</h3><div><sup>99m</sup><span><span>Tc-tetrofosmin is a diagnostic radiopharmaceutical<span> used to evaluate cardiac pathologies. Despite the lower incidence of reactions compared to other drugs, radiopharmaceuticals can still cause adverse reactions. For this reason, </span></span>pharmacovigilance plays a crucial role in detecting, understanding, evaluating and preventing them.</span></div></div><div><h3>Objective</h3><div>This study aims to review the available literature,on the safety of <sup>99m</sup><span>Tc-tetrofosmin, and to analyze spontaneous adverse drug reaction reports from the European EudraVigilance database.</span></div></div><div><h3>Methods</h3><div>A literature review was conducted according to PRISMA methodology. An analysis of spontaneous notifications was carried out in <em>EudraVigilance</em>, until 2022.</div></div><div><h3>Results</h3><div><span>The review identified a selection of 7 articles. The most reported adverse reactions were skin irritation, strange taste in the mouth and nausea. Regarding the </span><em>EudraVigilance</em> analysis, 220 notifications were identified, accounting for 477 adverse reactions. The majority belong to males (51%), between 18-64 years (45%). Health professionals were the main reporters (84%). The most prevalent <em>System Organ Class</em> was “general disorders and administration site conditions” (21%) and the most reported adverse reaction was pruritus (10%). Approximately 67% of reactions were considered serious, with 6 fatal cases recorded.</div></div><div><h3>Conclusion</h3><div>The results demonstrated that adverse reactions associated with <sup>99m</sup>Tc-tetrofosmin do occur and should not be minimized. Over a period of 17 years, only 220 notifications were recorded, which may highlight potential challenges in pharmacovigilance for radiopharmaceuticals. Therefore, raising awareness about the importance of reporting adverse reactions is crucial.</div></div>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"44 6","pages":"Article 500166"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144277164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
68Ga-FAPI and 18F-FDG PET/CT: Complementary imaging modalities for detecting unusual metastasis in a patient with osteosarcoma 68Ga-FAPI和18F-FDG PET/CT:检测骨肉瘤患者异常转移的互补成像方式
Pub Date : 2025-11-01 DOI: 10.1016/j.remnie.2025.500137
G.A. Divband , E. Askari , H.R. Amini , A.R. Noferesti , P. Sahafi
{"title":"68Ga-FAPI and 18F-FDG PET/CT: Complementary imaging modalities for detecting unusual metastasis in a patient with osteosarcoma","authors":"G.A. Divband ,&nbsp;E. Askari ,&nbsp;H.R. Amini ,&nbsp;A.R. Noferesti ,&nbsp;P. Sahafi","doi":"10.1016/j.remnie.2025.500137","DOIUrl":"10.1016/j.remnie.2025.500137","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"44 6","pages":"Article 500137"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aggressive ductal carcinoma presented with bilateral breast superscan on [18F]FDG PET/CT [18F]FDG PET/CT双侧乳腺超镜显示侵袭性导管癌。
Pub Date : 2025-11-01 DOI: 10.1016/j.remnie.2025.500163
Ahmed S. Abdlkadir , Enrique Estrada-Lobato , Kamal Al-Rabi , Akram Al-Ibraheem
{"title":"Aggressive ductal carcinoma presented with bilateral breast superscan on [18F]FDG PET/CT","authors":"Ahmed S. Abdlkadir ,&nbsp;Enrique Estrada-Lobato ,&nbsp;Kamal Al-Rabi ,&nbsp;Akram Al-Ibraheem","doi":"10.1016/j.remnie.2025.500163","DOIUrl":"10.1016/j.remnie.2025.500163","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"44 6","pages":"Article 500163"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One year of key contributions by the SEMNIM Oncology Group SEMNIM肿瘤小组一年的重要贡献
Pub Date : 2025-11-01 DOI: 10.1016/j.remnie.2025.500211
M. Rodríguez-Fraile
{"title":"One year of key contributions by the SEMNIM Oncology Group","authors":"M. Rodríguez-Fraile","doi":"10.1016/j.remnie.2025.500211","DOIUrl":"10.1016/j.remnie.2025.500211","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"44 6","pages":"Article 500211"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145468728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista espanola de medicina nuclear e imagen molecular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1